• bridgebio llc jobs

    Total searched jobs are :53

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-27-2021

    • BridgeBio Gene Therapy, a subsidiary of BridgeBio Pharma, is focused on discovering and developing drugs for patients with grievous genetic diseases. We do this by:Finding the right starting points to target diseases at their source.Using a combinati ...Read More

      Posted: 07-27-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-27-2021

    • QED Therapeutics, a subsidiary of BridgeBio Services, focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US ...Read More

      Posted: 07-27-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-27-2021

    • Who You Are:Are you someone that thrives in fast-paced and start-up environments? Do you want to make a difference in patients with genetic diseases? We seek a hard-working and detail-oriented Sr. Associate/Associate Director, Science Operations to a ...Read More

      Posted: 07-27-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-27-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-27-2021

    • BridgeBio Gene Therapy, a subsidiary of BridgeBio Pharma, is focused on discovering and developing drugs for patients with grievous genetic diseases. We do this by:Finding the right starting points to target diseases at their source.Using a combinati ...Read More

      Posted: 07-26-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-25-2021

    • BridgeBio Gene Therapy, a subsidiary of BridgeBio Pharma, is focused on discovering and developing drugs for patients with grievous genetic diseases. We do this by:Finding the right starting points to target diseases at their source.Using a combinati ...Read More

      Posted: 07-24-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-23-2021

    • QED Therapeutics, a subsidiary of BridgeBio Services, focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US ...Read More

      Posted: 07-21-2021

    • BridgeBio discovers, develops, and delivers breakthrough medicines for genetic diseases. The company combines remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients. Fou ...Read More

      Posted: 07-21-2021

    • QED Therapeutics, a subsidiary of BridgeBio Services, focuses on precision medicine for FGFR-driven cancers and diseases. The company's first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US ...Read More

      Posted: 07-19-2021

    • Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-d ...Read More

      Posted: 07-16-2021

    • BridgeBioX is a recently formed discovery research group where BridgeBio leverages extensive inherited disease experience and an established drug development infrastructure. The vision of BridgeBioX is to use cutting-edge biology to develop breakthro ...Read More

      Posted: 07-10-2021

    • Who You Are:Are you someone that thrives in fast-paced and start-up environments? Do you want to make a difference in patients with genetic diseases? We seek a hard-working and detail-oriented Sr. Associate/Associate Director, Science Operations to a ...Read More

      Posted: 07-10-2021

    • BridgeBioX is a recently formed discovery research group where BridgeBio leverages extensive inherited disease experience and an established drug development infrastructure. The vision of BridgeBioX is to use cutting-edge biology to develop breakthro ...Read More

      Posted: 07-08-2021

    • Who You Are:Are you someone that thrives in fast-paced and start-up environments? Do you want to make a difference in patients with genetic diseases? We seek a hard-working and detail-oriented Associate, Science Operations to advance critical project ...Read More

      Posted: 07-08-2021

    Search for us bridgebio llc jobs Save search criteria


    Filter Results By:

    • Refinements: